STARTER Checklist for Antimalarial Therapeutic Efficacy Reporting
Am J Trop Med Hyg
.
2022 Jun 13;107(1):1-3.
doi: 10.4269/ajtmh.22-0224.
Authors
Mateusz Plucinski
1
,
Elizabeth A Ashley
2
3
,
Quique Bassat
4
5
6
7
8
,
Meera Venkatesan
9
,
Philip J Rosenthal
10
,
Eric Halsey
1
Affiliations
1
U.S. President's Malaria Initiative, Malaria Branch, US Centers for Disease Control and Prevention, Atlanta, Georgia.
2
Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Vientiane, Laos.
3
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
4
ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.
5
Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
6
ICREA, Pg. Lluís Companys 23, 08010 Barcelona, Spain.
7
Pediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Esplugues, Barcelona, Spain.
8
Consorcio de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
9
U.S. President's Malaria Initiative, United States Agency for International Development, Washington, District of Columbia.
10
University of California San Francisco, San Francisco, California.
PMID:
35880678
PMCID:
PMC9294688
DOI:
10.4269/ajtmh.22-0224
No abstract available
Publication types
Editorial
Research Support, U.S. Gov't, Non-P.H.S.
MeSH terms
Antimalarials* / therapeutic use
Checklist
Folic Acid Antagonists*
Humans
Research Design
Substances
Antimalarials
Folic Acid Antagonists